Acadian Asset Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Hold |
133,525
| – | – | ﹤0.01% | 1097 |
|
|
2025
Q1 | $650K | Sell |
133,525
-12,141
| -8% | -$59.1K | ﹤0.01% | 1022 |
|
|
2024
Q4 | $977K | Sell |
145,666
-12,046
| -8% | -$80.8K | ﹤0.01% | 932 |
|
|
2024
Q3 | $1.22M | Sell |
157,712
-27,807
| -15% | -$215K | ﹤0.01% | 871 |
|
|
2024
Q2 | $1.11M | Buy |
185,519
+6,435
| +4% | +$38.6K | ﹤0.01% | 961 |
|
|
2024
Q1 | $1.61M | Buy |
179,084
+53,420
| +43% | +$481K | 0.01% | 710 |
|
|
2023
Q4 | $1.19M | Buy |
125,664
+42,495
| +51% | +$402K | ﹤0.01% | 811 |
|
|
2023
Q3 | $988K | Buy |
83,169
+53,376
| +179% | +$634K | ﹤0.01% | 855 |
|
|
2023
Q2 | $729K | Buy |
29,793
+28,341
| +1,952% | +$693K | ﹤0.01% | 960 |
|
|
2023
Q1 | $45K | Buy |
+1,452
| New | +$45K | ﹤0.01% | 1529 |
|
|
2022
Q3 | – | Sell |
-8,458
| Closed | -$700K | – | 1759 |
|
|
2022
Q2 | $700K | Buy |
+8,458
| New | +$700K | ﹤0.01% | 893 |
|
|
2022
Q1 | – | Sell |
-25,895
| Closed | -$4.33M | – | 1719 |
|
|
2021
Q4 | $4.33M | Sell |
25,895
-8,445
| -25% | -$1.41M | 0.02% | 483 |
|
|
2021
Q3 | $2.97M | Buy |
34,340
+684
| +2% | +$59.1K | 0.01% | 581 |
|
|
2021
Q2 | $1.83M | Hold |
33,656
| – | – | 0.01% | 732 |
|
|
2021
Q1 | $2.01M | Buy |
33,656
+977
| +3% | +$58.2K | 0.01% | 737 |
|
|
2020
Q4 | $1.71M | Buy |
32,679
+3,592
| +12% | +$188K | 0.01% | 808 |
|
|
2020
Q3 | $1.41M | Buy |
29,087
+7,347
| +34% | +$355K | 0.01% | 775 |
|
|
2020
Q2 | $1.13M | Buy |
21,740
+5,851
| +37% | +$303K | ﹤0.01% | 921 |
|
|
2020
Q1 | $693K | Buy |
15,889
+3,722
| +31% | +$162K | ﹤0.01% | 896 |
|
|
2019
Q4 | $488K | Buy |
12,167
+6,870
| +130% | +$276K | ﹤0.01% | 1078 |
|
|
2019
Q3 | $174K | Buy |
5,297
+3,914
| +283% | +$129K | ﹤0.01% | 1352 |
|
|
2019
Q2 | $107K | Buy |
+1,383
| New | +$107K | ﹤0.01% | 1361 |
|